1
|
Yasui W, Sentani K, Sakamoto N, Anami K,
Naito Y and Oue N: Molecular pathology of gastric cancer: research
and practice. Pathol Res Pract. 207:608–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Samson PS, Escovidal LA, Yrastorza SG,
Veneracion RG and Nerves MY: Re-study of gastric cancer: analysis
of outcome. World J Surg. 26:428–433. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Wu C and Alman BA: Side population cells
in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar
|
5
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar
|
6
|
Burkert J, Wright NA and Alison MR: Stem
cells and cancer: an intimate relationship. J Pathol. 209:287–297.
2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Jordan CT, Guzman ML and Noble M: Cancer
stem cells. N Engl J Med. 355:1253–1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shimano K, Satake M, Okaya A, Kitanaka J,
Kitanaka N, Takemura M, Sakagami M, Terada N and Tsujimura T:
Hepatic oval cells have the side population phenotype defined by
expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J
Pathol. 163:3–9. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lechner A, Leech CA, Abraham EJ, Nolan AL
and Habener JF: Nestin-positive progenitor cells derived from adult
human pancreatic islets of Langerhans contain side population (SP)
cells defined by expression of the ABCG2 (BCRP1) ATP-binding
cassette transporter. Biochem Biophys Res Commun. 293:670–674.
2002. View Article : Google Scholar
|
12
|
Hirschmann-Jax C, Foster AE, Wulf GG,
Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct
‘side population’ of cells with high drug efflux capacity in human
tumor cells. Proc Natl Acad Sci USA. 101:14228–14233. 2004.
|
13
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Dean M, Fojo T and Bates S: Tumor stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
15
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lee J, Kotliarova S, Kotliarov Y, Li A, Su
Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK
and Fine HA: Tumor stem cells derived from glioblastomas cultured
in bFGF and EGF more closely mirror the phenotype and genotype of
primary tumors than do serum-cultured cell lines. Cancer Cell.
9:391–403. 2006. View Article : Google Scholar : PubMed/NCBI
|
17
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radio-resistance by preferential activation of the
DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Mao F, Leung WY and Xin X:
Characterization of EvaGreen and the implication of its
physicochemical properties for qPCR applications. BMC Biotechnol.
7:762007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Rosner MH, Vigano MA, Ozato K, Timmons PM,
Poirier F, Rigby PW and Staudt LM: A POU-domain transcription
factor in early stem cells and germ cells of the mammalian embryo.
Nature. 345:686–692. 1990. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Okita K, Ichisaka T and Yamanaka S:
Generation of germline-competent induced pluripotent stem cells.
Nature. 448:313–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Park IH, Zhao R, West JA, Yabuuchi A, Huo
H, Ince TA, Lerou PH, Lensch MW and Daley GQ: Reprogramming of
human somatic cells to pluripotency with defined factors. Nature.
451:141–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Yu J, Vodyanik MA, Smuga-Otto K,
Antosiewicz-Bourget J, Frane JL, Tian S, et al: Induced pluripotent
stem cell lines derived from human somatic cells. Science.
318:1917–1920. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Olempska M, Eisenach PA, Ammerpohl O,
Ungefroren H, Fandrich F and Kalthoff H: Detection of tumor stem
cell markers in pancreatic carcinoma cell lines. Hepatobiliary
Pancreat Dis Int. 6:92–97. 2007.PubMed/NCBI
|
25
|
Fukuda K, Saikawa Y, Ohashi M, Kumagai K,
Kitajima M, Okano H, Matsuzaki Y and Kitagawa Y: Tumor initiating
potential of side population cells in human gastric cancer. Int J
Oncol. 34:1201–1207. 2009.PubMed/NCBI
|
26
|
Chen YC, Hsu HS, Chen YW, Tsai TH, How CK,
et al: Oct-4 expression maintained cancer stem-like properties in
lung cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Jia Q, Zhang X, Deng T and Gao J: Positive
correlation of Oct4 and ABCG2 to chemotherapeutic resistance in
CD90(+)CD133(+) liver cancer stem cells. Cell Reprogram.
15:143–150. 2013.PubMed/NCBI
|
28
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks P: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
29
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
30
|
Gibbs CP, Kukekov VG, Reith JD,
Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and
Steindler DA: Stem-like cells in bone sarcomas: implications for
tumorigenesis. Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Fang D, Nguyen TK, Leishear K, Finko R,
Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE and Herlyn M: A
tumorigenic subpopulation with stem cell properties in melanomas.
Cancer Res. 65:9328–9337. 2005. View Article : Google Scholar : PubMed/NCBI
|
32
|
Gou S, Liu T, Wang C, Yin T, Li K, Yang M
and Zhou J: Establishment of clonal colony-forming assay for
propagation of pancreatic cancer cells with stem cell properties.
Pancreas. 34:429–435. 2007. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zhang S, Balch C, Chan MW, Lai HC, Matei
D, Schilder JM, Yan PS, Huang TH and Nephew KP: Identification and
characterization of ovarian cancer-initiating cells from primary
human tumors. Cancer Res. 68:4311–4320. 2008. View Article : Google Scholar : PubMed/NCBI
|
34
|
Fujii H, Honoki K, Tsujiuchi T, Kido A,
Yoshitani K and Takakura Y: Sphere-forming stem-like cell
populations with drug resistance in human sarcoma cell lines. Int J
Oncol. 34:1381–1386. 2009.PubMed/NCBI
|
35
|
Rappa G, Mercapide J, Anzanello F,
Prasmickaite L, Xi Y, Ju J, Fodstad O and Lorico A: Growth of
cancer cell lines under stem cell-like conditions has the potential
to unveil therapeutic targets. Exp Cell Res. 314:2110–2122. 2008.
View Article : Google Scholar : PubMed/NCBI
|